Paris, France Munich, Germany – May perhaps 18, 2020
Atos, a worldwide leader in electronic transformation and Siemens, a worldwide engineering leader, are performing jointly with the pharmaceutical industry to make improvements to production with an ground breaking solution dependent on a electronic replica of the pharma production procedure. At this time getting analyzed in the pharmaceutical marketplace, this ground breaking “Method Electronic Twin” for pharma producing – driven by IoT, AI and Sophisticated Analytics – is designed to give improved efficiency and flexibility in the producing of pharmaceutical items.
Based on the pilot study, this probably disruptive solution opens up new chances, these as a sustainable procedure progress – cutting down over-all experimentation time and waste, ensuring frequent quality and going to new “quality by design” models to get the item suitable the 1st time. The solution also gives optimized steps for procedure quality and dependability.
The production and launch of pharmaceutical items are elaborate and lengthy processes. To meet these troubles, one of Atos and Siemens’ worldwide pharmaceutical partners has determined to check a new ground breaking solution, constructed and created by a joint financial commitment and business collaboration from the Atos-Siemens strategic worldwide alliance. The “Process Electronic Twin” is a full virtual replica of a unique action in the producing procedure, linked with IoT sensors installed on the actual plant.
It generates volumes of elaborate data and offers an fast perspective of all aspects of the operations. By pairing virtual and actual physical representations of the procedure, and making use of predictive models and actual-time analytics, Atos and Siemens are encouraging the pharmaceutical marketplace to reinvent essential aspects of the producing surroundings.
“We are delighted to deliver electronic technologies to the coronary heart of the worldwide pharmaceutical marketplace, encouraging it meet the multiple overall health troubles of nowadays and tomorrow.” states Paul Albada Jelgersma, SVP, Global Head of Codex providers for IoT & Siemens MindSphere at Atos. “With the Method Electronic Twin created by Atos and Siemens, a good electronic footprint of pharmaceutical items is designed throughout the procedure progress cycle, setting up from the layout stage, all the way to production.”
“Digitalization at each and every point along the price chain will most likely assistance the pharma marketplace get prescribed drugs from the lab to the affected person far more swiftly.” states Rebecca Vangenechten, Head of business Pharmaceutical Market at Siemens. “This was a difficult journey in which the partners designed the foundation for future procedure progress & producing, dependent on science, engineering and innovation”.
Atos gives its experience in IT infrastructure, consulting, integration and data science, notably from its Codex experience in AI and IoT alternatives and providers – even though Siemens gives its Electronic Business experience in OT devices for Pharma, notably with Simatic Sipat for actual-time quality checking and StarCCM+ & HEEDS for procedure modeling & simulation.
The mother nature of Atos and Siemens’ pre-built-in Electronic Twin solution makes it possible for it to be deployed